TEVA News and Press, Teva Pharmaceutical Industries Limited American Depositary Shares From 02/20/26

2026-02-20 00:45:00 ET The following segment was excerpted from the Allspring Mid Cap Growth Fund Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Allspring Mid Cap Growth Fund Q4 2025 Performance In...

2026-02-19 11:10:48 ET More on Corcept Therapeutics Why Corcept Therapeutics' Relacorilant Fell Short And What It Means For The Company Corcept: Korlym Defies Generics As Relacorilant Hits An FDA CRL (Rating Upgrade) Corcept Therapeutics: Despite FDA Blind Side, Rela...

2026-02-19 10:07:31 ET Last October 2025, Bausch Health Companies Inc. ( BHC ) jumped by 1% after it posted third quarter results . This time, the fourth-quarter bottom line missed expectations. Both its revenue for Q4 and revenue guidance for 2026 exceeded consensus. However, t...

2026-02-17 10:54:57 ET Teva Pharmaceutical Industries Limited (TEVA) Discusses Duvakitug IBD Phase 2b Maintenance Top-Line Results February 17, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Teva Pharmaceutical Industries Limited (TEVA) D...

2026-02-17 06:15:51 ET Read the full article on Seeking Alpha For further details see: Teva, Sanofi report durable phase 2b efficacy for duvakitug in ulcerative colitis, Crohn’s disease

In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of induction Duvakitug was well tolerated and safety was consistent with the induction study Findings reinforce the potential of du...

2026-02-12 14:16:00 ET Steady execution on sales and clinical development builds value over time for biotechs but tends to be rather boring from a market sentiment standpoint. Neurocrine Biosciences ( NBIX ) is doing the right things to build value for its shareholders, but 2026 is look...

2026-02-05 14:26:57 ET Image source: The Motley Fool. Wednesday, January 29, 2025 at 8 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-05 14:26:23 ET Image source: The Motley Fool. Wednesday, November 6, 2024 at 8:00 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-02-05 12:47:24 ET Harel Insurance Investments & Financial Services Ltd. disclosed in its Feb. 3, 2026, SEC filing that it sold 4,177,000 shares of the Invesco KBW Bank ETF (KBWB), an estimated $330 million transaction based on the quarterly average price. According to a filin...